Cancer treatment outcomes are influenced not only by clinical and demographic factors but also by the collaboration of healthcare teams. However, prior work has largely overlooked the potential role of human collaboration in shaping patient survival. This paper presents an applied AI approach to uncovering the impact of healthcare professionals' (HCPs) collaboration--captured through electronic health record (EHR) systems--on cancer patient outcomes. We model EHR-mediated HCP interactions as networks and apply machine learning techniques to detect predictive signals of patient survival embedded in these collaborations. Our models are cross validated to ensure generalizability, and we explain the predictions by identifying key network traits associated with improved outcomes. Importantly, clinical experts and literature validate the relevance of the identified crucial collaboration traits, reinforcing their potential for real-world applications. This work contributes to a practical workflow for leveraging digital traces of collaboration and AI to assess and improve team-based healthcare. The approach is potentially transferable to other domains involving complex collaboration and offers actionable insights to support data-informed interventions in healthcare delivery.

Fine-grained analysis of intraoperative behavior and its impact on patient outcomes remain a longstanding challenge. We present Frame-to-Outcome (F2O), an end-to-end system that translates tissue dissection videos into gesture sequences and uncovers patterns associated with postoperative outcomes. Leveraging transformer-based spatial and temporal modeling and frame-wise classification, F2O robustly detects consecutive short (~2 seconds) gestures in the nerve-sparing step of robot-assisted radical prostatectomy (AUC: 0.80 frame-level; 0.81 video-level). F2O-derived features (gesture frequency, duration, and transitions) predicted postoperative outcomes with accuracy comparable to human annotations (0.79 vs. 0.75; overlapping 95% CI). Across 25 shared features, effect size directions were concordant with small differences (~ 0.07), and strong correlation (r = 0.96, p < 1e-14). F2O also captured key patterns linked to erectile function recovery, including prolonged tissue peeling and reduced energy use. By enabling automatic interpretable assessment, F2O establishes a foundation for data-driven surgical feedback and prospective clinical decision support.

We would like to thank all reviewers for their valuable feedback which has helped us improve the paper! Upon acceptance, we will release the code for the model and for the semi-synthetic data generation. Metrics are reported as Mean Std. We will add discussion about this in the conclusion. Evaluation on semi-synthetic data is standard for causal inference methods.

The rapid advancement of Large Language Models (LLMs) has stimulated interest in multi-agent collaboration for addressing complex medical tasks. However, the practical advantages of multi-agent collaboration approaches remain insufficiently understood. Existing evaluations often lack generalizability, failing to cover diverse tasks reflective of real-world clinical practice, and frequently omit rigorous comparisons against both single-LLM-based and established conventional methods. To address this critical gap, we introduce MedAgentBoard, a comprehensive benchmark for the systematic evaluation of multi-agent collaboration, single-LLM, and conventional approaches. MedAgentBoard encompasses four diverse medical task categories: (1) medical (visual) question answering, (2) lay summary generation, (3) structured Electronic Health Record (EHR) predictive modeling, and (4) clinical workflow automation, across text, medical images, and structured EHR data. Our extensive experiments reveal a nuanced landscape: while multi-agent collaboration demonstrates benefits in specific scenarios, such as enhancing task completeness in clinical workflow automation, it does not consistently outperform advanced single LLMs (e.g., in textual medical QA) or, critically, specialized conventional methods that generally maintain better performance in tasks like medical VQA and EHR-based prediction. MedAgentBoard offers a vital resource and actionable insights, emphasizing the necessity of a task-specific, evidence-based approach to selecting and developing AI solutions in medicine. It underscores that the inherent complexity and overhead of multi-agent collaboration must be carefully weighed against tangible performance gains. All code, datasets, detailed prompts, and experimental results are open-sourced at https://medagentboard.netlify.app/.

Carbapenemase-Producing Enterobacteriace poses a critical concern for infection prevention and control in hospitals. However, predictive modeling of previously highlighted CPE-associated risks such as readmission, mortality, and extended length of stay (LOS) remains underexplored, particularly with modern deep learning approaches. This study introduces an eXplainable AI modeling framework to investigate CPE impact on patient outcomes from Electronic Medical Records data of an Irish hospital. We analyzed an inpatient dataset from an Irish acute hospital, incorporating diagnostic codes, ward transitions, patient demographics, infection-related variables and contact network features. Several Transformer-based architectures were benchmarked alongside traditional machine learning models. Clinical outcomes were predicted, and XAI techniques were applied to interpret model decisions. Our framework successfully demonstrated the utility of Transformer-based models, with TabTransformer consistently outperforming baselines across multiple clinical prediction tasks, especially for CPE acquisition (AUROC and sensitivity). We found infection-related features, including historical hospital exposure, admission context, and network centrality measures, to be highly influential in predicting patient outcomes and CPE acquisition risk. Explainability analyses revealed that features like "Area of Residence", "Admission Ward" and prior admissions are key risk factors. Network variables like "Ward PageRank" also ranked highly, reflecting the potential value of structural exposure information. This study presents a robust and explainable AI framework for analyzing complex EMR data to identify key risk factors and predict CPE-related outcomes. Our findings underscore the superior performance of the Transformer models and highlight the importance of diverse clinical and network features.

In pharmaceutical R&D, predicting the efficacy of a pharmaceutical in treating a particular disease prior to clinical testing or any real-world use has been challenging. In this paper, we propose a flexible and modular machine learning-based approach for predicting the efficacy of an untested pharmaceutical for treating a disease. We train a machine learning model using sets of pharmaceutical-pathway weight impact scores and patient data, which can include patient characteristics and observed clinical outcomes. The resulting model then analyses weighted impact scores of an untested pharmaceutical across human biological molecule-protein pathways to generate a predicted efficacy value. We demonstrate how the method works on a real-world dataset with patient treatments and outcomes, with two different weight impact score algorithms We include methods for evaluating the generalisation performance on unseen treatments, and to characterise conditions under which the approach can be expected to be most predictive. We discuss specific ways in which our approach can be iterated on, making it an initial framework to support future work on predicting the effect of untested drugs, leveraging RWD clinical data and drug embeddings.

We would like to thank all reviewers for their valuable feedback which has helped us improve the paper! Upon acceptance, we will release the code for the model and for the semi-synthetic data generation. Metrics are reported as Mean Std. We will add discussion about this in the conclusion. Evaluation on semi-synthetic data is standard for causal inference methods.

Background Sepsis is a life - threatening condition affecting over 48.9 million people globally and causing 11 million deaths annually. Despite medical advancements, predicting sepsis remains a challenge due to non - specific symptoms and complex pathophysiology. The SXI++ LNM model is a machine learning - based scoring system that refines sepsis prediction by leveraging multiple algorithms and deep neural networks. The COMPOSER model, a de ep learning framework utilizing conformal prediction, aims to improve robustness in clinical applications. This study compares the predictive performance of SXI++ LNM and COMPOSER for sepsis prediction. Methods A dataset containing 1,552,210 rows with 43 columns was cleaned and refined to 964,355 rows and 14 key features for sepsis prediction. Data were sourced from ICU patients across three separate hospital systems, including two publicly available datasets fro m Kaggle and the Early Prediction of Sepsis from Clinical Data: The PhysioNet/Computing in Cardiology Challenge 2019.

Artificial Intelligence (AI) is revolutionizing emergency medicine by enhancing diagnostic processes and improving patient outcomes. This article provides a comprehensive review of the current applications of AI in emergency imaging studies, focusing on the last five years of advancements. AI technologies, particularly machine learning and deep learning, are pivotal in interpreting complex imaging data, offering rapid, accurate diagnoses and potentially surpassing traditional diagnostic methods. Studies highlighted within the article demonstrate AI's capabilities in accurately detecting conditions such as fractures, pneumothorax, and pulmonary diseases from various imaging modalities including X-rays, CT scans, and MRIs. Furthermore, AI's ability to predict clinical outcomes like mechanical ventilation needs illustrates its potential in crisis resource optimization. Despite these advancements, the integration of AI into clinical practice presents challenges such as data privacy, algorithmic bias, and the need for extensive validation across diverse settings. This review underscores the transformative potential of AI in emergency settings, advocating for a future where AI and clinical expertise synergize to elevate patient care standards.

We present a deep learning-based approach to studying dynamic clinical behavioral regimes in diverse non-randomized healthcare settings. Our proposed methodology - deep causal behavioral policy learning (DC-BPL) - uses deep learning algorithms to learn the distribution of high-dimensional clinical action paths, and identifies the causal link between these action paths and patient outcomes. Specifically, our approach: (1) identifies the causal effects of provider assignment on clinical outcomes; (2) learns the distribution of clinical actions a given provider would take given evolving patient information; (3) and combines these steps to identify the optimal provider for a given patient type and emulate that provider's care decisions. Underlying this strategy, we train a large clinical behavioral model (LCBM) on electronic health records data using a transformer architecture, and demonstrate its ability to estimate clinical behavioral policies. We propose a novel interpretation of a behavioral policy learned using the LCBM: that it is an efficient encoding of complex, often implicit, knowledge used to treat a patient. This allows us to learn a space of policies that are critical to a wide range of healthcare applications, in which the vast majority of clinical knowledge is acquired tacitly through years of practice and only a tiny fraction of information relevant to patient care is written down (e.g. in textbooks, studies or standardized guidelines).